Lincoln Pharmaceuticals Complete Financial Statements
LINCOLN • Review detailed financials to uncover trends, confirm thesis & journal trades
11 Years of Data
2025 - 2015
Complete Financial Data Export
Export complete financial statements for Lincoln Pharmaceuticals (LINCOLN).
Downloads include all available records across all periods.
For market performance, see the
LINCOLN stock price today
.
Profitability Ratios
Net Profit Margin
11.70%
2025 data
EBITDA Margin
19.30%
2025 data
Operating Margin
16.00%
2025 data
Return on Assets
2.51%
2025 data
Return on Equity
2.98%
2025 data
Balance Sheet Ratios
Current Ratio
26.32
2025 data
Debt to Equity
1.19
2025 data
Equity Ratio
84.32%
2025 data
Asset Turnover
0.21
2025 data
Year-over-Year Growth Analysis
Comparing Sept 2024 vs Sept 2025
Net Profit Growth
-23.1%
Year-over-Year
EBITDA Growth
-13.2%
Year-over-Year
Expense Growth
+3.8%
Year-over-Year
Assets Growth
+13.9%
Year-over-Year
Equity Growth
+13.3%
Year-over-Year
Liabilities Growth
+13.9%
Year-over-Year
Operating Cash Flow Growth
+47.6%
Year-over-Year
Investing Cash Flow Growth
-38.6%
Year-over-Year
Financing Cash Flow Growth
-20.0%
Year-over-Year
Income Statement
Periods
₹ Crores
| Particulars | Sept 2025 | Mar 2025 | Jun 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 171 | 161 | 169 | 171 | 150 | 158 | 156 | 165 | 116 | 143 | 158 | 146 | 105 | 130 | 140 | 131 | 82 | 124 | 123 | 127 | 83 | 106 | 116 | 115 | 78 | 98 | 102 | 107 | 68 | 102 | 85 | 93 | 119 | 152 | 83 | 78 | 129 | 93 | 74 | 91 | 79 | 73 | 105 |
| Expenses | 138 | 142 | 130 | 133 | 124 | 125 | 123 | 125 | 96 | 115 | 117 | 112 | 85 | 107 | 107 | 98 | 64 | 97 | 96 | 96 | 70 | 82 | 95 | 88 | 68 | 78 | 85 | 84 | 58 | 77 | 71 | 74 | 115 | 143 | 64 | 63 | 117 | 74 | 62 | 84 | 71 | 64 | 95 |
| EBITDA | 33 | 20 | 39 | 38 | 25 | 33 | 33 | 40 | 21 | 28 | 41 | 35 | 19 | 23 | 33 | 33 | 18 | 27 | 26 | 30 | 13 | 24 | 21 | 27 | 10 | 20 | 16 | 24 | 11 | 26 | 14 | 18 | 4 | 10 | 19 | 15 | 12 | 19 | 12 | 8 | 7 | 9 | 10 |
| Operating Profit Margin % | 16.00% | 16.00% | 15.00% | 18.00% | 13.00% | 15.00% | 16.00% | 20.00% | 15.00% | 15.00% | 20.00% | 21.00% | 17.00% | 14.00% | 20.00% | 23.00% | 19.00% | 21.00% | 20.00% | 24.00% | 11.00% | 21.00% | 17.00% | 22.00% | 14.00% | 20.00% | 13.00% | 19.00% | 14.00% | 23.00% | 16.00% | 17.00% | 3.00% | 5.00% | 20.00% | 16.00% | 3.00% | 17.00% | 12.00% | 8.00% | 9.00% | 12.00% | 9.00% |
| Depreciation | 4 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -1 | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 4 | 2 | 1 | 2 | 3 | 2 | 2 |
| Profit Before Tax | 29 | 16 | 35 | 35 | 22 | 30 | 29 | 37 | 17 | 26 | 38 | 32 | 17 | 21 | 31 | 31 | 15 | 25 | 24 | 29 | 12 | 21 | 18 | 25 | 8 | 18 | 13 | 20 | 8 | 23 | 11 | 15 | 1 | 7 | 16 | 12 | 6 | 15 | 9 | 9 | 3 | 8 | 10 |
| Tax | 9 | 5 | 8 | 8 | 4 | 6 | 8 | 9 | 4 | 6 | 10 | 8 | 6 | 6 | 9 | 8 | 3 | 7 | 6 | 8 | 3 | 6 | 5 | 6 | -1 | 5 | 2 | 5 | 1 | 7 | 2 | 4 | 0 | 2 | 5 | 3 | 2 | 4 | 3 | 2 | 1 | 2 | 3 |
| Net Profit | 20 | 12 | 28 | 26 | 19 | 24 | 21 | 28 | 13 | 19 | 28 | 24 | 11 | 15 | 22 | 23 | 13 | 18 | 18 | 21 | 9 | 15 | 14 | 19 | 9 | 13 | 11 | 15 | 7 | 16 | 9 | 11 | 1 | 5 | 12 | 9 | 4 | 11 | 7 | 7 | 2 | 7 | 7 |
| Earnings Per Share (₹) | 9.98 | 5.78 | 13.82 | 13.15 | 9.28 | 11.82 | 10.37 | 13.81 | 6.27 | 9.49 | 14.00 | 11.84 | 5.50 | 7.49 | 10.79 | 11.50 | 6.29 | 8.85 | 8.79 | 10.46 | 4.47 | 7.63 | 6.73 | 9.46 | 4.25 | 6.33 | 5.46 | 7.50 | 3.42 | 8.03 | 4.57 | 5.65 | 0.66 | 2.46 | 5.79 | 5.42 | 2.46 | 6.99 | 3.27 | 4.10 | 1.35 | 4.01 | 3.95 |
Related Pages for Lincoln Pharmaceuticals
Additional stock information and data for LINCOLN
Balance Sheet
Years
Annual Data
₹ Crores
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Total Assets | 797 | 700 | 587 | 534 | 452 | 389 | 366 | 347 | 305 | 275 | 258 |
| Current Assets | 500 | 447 | 367 | 353 | 309 | 248 | 224 | 218 | 181 | 147 | 177 |
| Fixed Assets | 182 | 179 | 151 | 132 | 111 | 123 | 121 | 117 | 103 | 99 | 66 |
| Capital Work in Progress | 5 | 4 | 7 | 16 | 2 | 0 | 2 | 0 | 7 | 3 | 3 |
| Investments | 174 | 139 | 91 | 97 | 81 | 34 | 18 | 11 | 10 | 0 | 0 |
| Other Assets | 437 | 379 | 339 | 290 | 259 | 232 | 225 | 219 | 186 | 174 | 190 |
| LIABILITIES | |||||||||||
| Total Liabilities | 797 | 700 | 587 | 534 | 452 | 389 | 366 | 347 | 305 | 275 | 258 |
| Current Liabilities | 19 | 15 | 13 | 11 | 10 | 10 | 11 | 18 | 22 | 34 | 33 |
| Non-Current Liabilities | |||||||||||
| SHAREHOLDERS' EQUITY | |||||||||||
| Total Equity | 672 | 593 | 503 | 433 | 366 | 314 | 270 | 225 | 193 | 141 | 114 |
| Share Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 16 | 16 |
| Reserves & Surplus | 652 | 573 | 482 | 413 | 346 | 293 | 249 | 204 | 172 | 117 | 95 |
Cash Flow Statement
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 93 | 63 | 39 | 76 | 69 | 75 | 53 | 27 | 25 | 45 | 25 |
| Investing Activities | -79 | -57 | -37 | -78 | -64 | -31 | -18 | -12 | -26 | -42 | 7 |
| Financing Activities | -6 | -5 | -5 | -3 | -6 | -38 | -36 | -11 | 0 | -3 | -32 |
| Net Cash Flow | 8 | 1 | -2 | -5 | -1 | 7 | -1 | 4 | 0 | 0 | -1 |